Prelude Capital Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-11
Closed -$1K 1832
2019
Q3
$1K Buy
+11
New +$1K ﹤0.01% 1134